Gurpal Virdi, MD

San Francisco Bay Area Ophthalmologist

Gurpal Virdi, MDRefractive, cataract, and anterior segment surgeon

An ophthalmologist from the San Francisco Bay Area, currently completing a refractive surgery fellowship at Parkhurst NuVision in San Antonio, Texas, under Dr. Gregory Parkhurst, principal investigator of the FDA EVO ICL trial. I perform the full range of anterior segment surgery:

My peer-reviewed research focuses on EVO ICL sizing and fit. Alongside clinical practice I build software for refractive and cataract surgery, including the ICL Fit AI agent, and conduct research in AI.

Get in touch Full CV
Gurpal Virdi, MD, refractive and cataract surgeon from the San Francisco Bay Area

Procedures

Choosing between them: the question patients ask most has its own page, EVO ICL vs LASIK, and every procedure above is written up in full on the blog.

Platforms: EVO ICL & EVO+ · excimer and femtosecond lasers · IOLs (monofocal, toric, multifocal, EDOF, light-adjustable) · MIGS (iDose TR, iStent, OMNI). Lens selection draws on IOL Reference, the intraocular lens technology platform I built and maintain, used by cataract surgeons worldwide to compare lens designs, optical principles, materials and specifications side by side. How the choice is actually made is set out on cataract surgery & IOL selection.

Get in touch

For consultation inquiries, research collaboration, speaking, or media, email is best and I reply personally.

gvirdimd@gmail.com